Recursion Pharmaceuticals (RXRX) Share-based Compensation (2020 - 2026)
Recursion Pharmaceuticals (RXRX) reported Share-based Compensation of $19.5 million for Q2 2026, down 25.5% from $26.16 million a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' Share-based Compensation came in at $90.72 million, down 18.5% year-over-year; for FY2025, it came in at $111.22 million, up 36.2% from FY2024.
- Share-based Compensation has increased for six consecutive years, with a five-year compound annual growth rate of 91.7% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $81.69 million in FY2024 (+52.7%), $53.5 million in FY2023 (+91.7%), $27.91 million in FY2022 (+88.0%) and $14.84 million in FY2021 (+245.8%).
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q3 2024.
- Year over year, Share-based Compensation has now declined in each of the last three quarters, with growth averaging 29.2% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 265.4%); the low point was Q1 2026 (a decline of 38.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $22.22 million (Q1 2026), $23.76 million (Q4 2025) and $25.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 19.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.50 Mn |
| Mar 31, 2026 | 22.22 Mn |
| Dec 31, 2025 | 23.76 Mn |
| Sep 30, 2025 | 25.24 Mn |
| Jun 30, 2025 | 26.16 Mn |
| Mar 31, 2025 | 36.06 Mn |
| Dec 31, 2024 | 30.78 Mn |
| Sep 30, 2024 | 18.25 Mn |
| Jun 30, 2024 | 16.52 Mn |
| Mar 31, 2024 | 16.13 Mn |
| Dec 31, 2023 | 16.09 Mn |
| Sep 30, 2023 | 16.79 Mn |
| Jun 30, 2023 | 11.81 Mn |
| Mar 31, 2023 | 8.81 Mn |
| Dec 31, 2022 | 7.70 Mn |
| Sep 30, 2022 | 8.91 Mn |
| Jun 30, 2022 | 5.68 Mn |
| Mar 31, 2022 | 5.63 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 3.36 Mn |
API Access
Recursion Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();